Philanthropic Capital: Life Science's Untapped Opportunity

Mon, Nov 16, 2026 · 3:30–4:15 PM GMT Old Billingsgate

About this session

Philanthropic capital represents a powerful yet underutilized funding source in the life sciences ecosystem. While venture capital and public markets dominate the conversation around biotech and medtech financing, philanthropic organizations, family offices, and mission-driven foundations are increasingly stepping into early-stage innovation—often filling critical gaps that traditional investors won't touch.

Speakers

Torquil Jackson

Investment Manager · Cancer Research Horizons

Moderator
Everett Kamin

Chief Investment Officer · Gemini Capital Partners

Panelist
Felix Litzkow

Head of Macmillan Ventures · Macmillan Cancer Support

Panelist
Robert Smith

Founder & CEO · Conscious Capital

Panelist
Colleen Acosta

Co-Founder & CEO · Freya Biosciences

Panelist